Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JCO Precision Oncology|September 3, 2021
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard TherapiesAndrew Hendifar, Edik M Blais, Brian Wolpin, et al.
Plos One|November 9, 2013
Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimensDustin M Walters, Jayme B Stokes, Sara J Adair, et al.
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
British Journal of Cancer|July 12, 2019
Multi-omic molecular comparison of primary versus metastatic pancreatic tumoursGagandeep Brar, Edik M Blais, R Joseph Bender, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the LiteratureMedhavi Gupta, Christopher Sherrow, Maghan E Krone, et al.
The Lancet. Oncology|March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
JCO Precision Oncology|February 1, 2022
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor ProgramMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor InitiativeMichael J Pishvaian, Robert J Bender, David Halverson, et al.
American Journal of Clinical Pathology|April 20, 2024
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinomaLyanne A Delgado-Coka, Lucia Roa-Peña, Sruthi Babu, et al.
JAMIA Open|February 7, 2020
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patientsMichael J Pishvaian, Edik M Blais, R Joseph Bender, et al.
Pageof 3